Watch this video to explore Bio-Rad’s state-of-the-art facility in Neuried, near Munich, Germany — a hub driving innovation in biotherapeutic discovery. With over 20 years of expertise and a legacy of developing over 60,000 antibodies, Bio-Rad is redefining antibody discovery. See how Bio-Rad’s Pioneer Antibody Discovery Platform fast-tracks your antibody discovery programs to identify clinical-quality candidates in industry-leading timelines.

The Pioneer Platform features one of the largest functional antibody libraries available, utilizing SpyLock technology for rapid prototyping and screening of hundreds of bispecific antibodies, and TrailBlazer technology for efficient antibody format conversion. Together, these services provide a comprehensive and streamlined solution for researchers seeking to develop innovative biotherapeutic therapies.

Watch now to explore how Bio-Rad is transforming antibody discovery.

Tags:,,,,
Previous post

Maximizing PCR and qPCR Throughput with Automated Solutions

Next post

Global Lung Cancer Expert Dr. Ed Schuuring on How ddPCR Technology Powers ctDNA Analysis